Renalytix (RNLX) Short Interest Ratio & Short Volume → Biggest Prediction of My 50-Year Career on Wall Street (From Chaikin Analytics) (Ad) Free RNLX Stock Alerts $0.43 0.00 (0.00%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Renalytix Short Interest DataCurrent Short Interest446,600 sharesPrevious Short Interest627,400 sharesChange Vs. Previous Month-28.82%Dollar Volume Sold Short$253,222.20Short Interest Ratio0.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares77,180,000 sharesPercentage of Shares Shorted0.58%Today's Trading Volume249,573 sharesAverage Trading Volume1,292,135 sharesToday's Volume Vs. Average19% Short Selling Renalytix ? Sign up to receive the latest short interest report for Renalytix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNLX Short Interest Over TimeRNLX Days to Cover Over TimeRNLX Percentage of Float Shorted Over Time Ad DTIThree basic steps to building the Ultimate Dividend Portfolio.There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free). Renalytix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024446,600 shares $253,222.20 -28.8%N/A0.6 $0.57 4/30/2024627,400 shares $435,352.86 -6.9%N/A0.3 $0.69 4/15/2024673,700 shares $567,659.62 -15.3%N/A0.4 $0.84 3/31/2024795,200 shares $683,872.00 -11.1%N/A0.4 $0.86 3/15/2024894,600 shares $769,356.00 +78.7%N/A0.5 $0.86 2/29/2024500,600 shares $585,702.00 -60.6%N/A0.3 $1.17 Get the Latest News and Ratings for RNLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renalytix and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,270,000 shares $997,331.00 +111.0%N/A1 $0.79 1/31/2024601,800 shares $190,650.24 -10.5%N/A2.3 $0.32 1/15/2024672,200 shares $215,104.00 +145.3%N/A3.3 $0.32 12/31/2023274,000 shares $106,860.00 +350.7%N/A2.1 $0.39 12/15/202360,800 shares $22,204.16 -68.9%N/A0.5 $0.37 11/30/2023195,500 shares $92,862.50 -11.5%N/A1.9 $0.48 11/15/2023221,000 shares $130,611.00 -36.5%N/A2.3 $0.59 10/31/2023347,800 shares $361,712.00 +65.6%N/A4.4 $1.04 10/15/2023210,000 shares $243,600.00 +32.4%N/A2.7 $1.16 9/30/2023158,600 shares $253,760.00 -69.2%N/A1.7 $1.60 9/15/2023514,700 shares $1.09 million +4.8%N/A0.8 $2.11 8/31/2023491,000 shares $1.42 million +10.2%N/A0.8 $2.90 8/15/2023445,700 shares $1.14 million -3.8%N/A0.7 $2.55 7/31/2023463,400 shares $1.34 million -40.4%N/A0.7 $2.90 7/15/2023777,400 shares $2.92 million +123.2%N/A1.2 $3.76 6/30/2023348,300 shares $1.02 million -6.5%N/A0.6 $2.92 6/15/2023372,400 shares $871,416.00 -3.3%N/A8.1 $2.34 5/31/2023385,200 shares $943,740.00 +44.9%N/A8.3 $2.45 5/15/2023265,900 shares $582,321.00 -20.0%N/A6.6 $2.19 4/30/2023332,500 shares $788,025.00 +7.7%N/A7.5 $2.37 4/15/2023308,600 shares $765,328.00 +52.6%N/A6.2 $2.48 3/31/2023202,300 shares $489,566.00 +43.6%N/A4.1 $2.42 3/15/2023140,900 shares $324,070.00 +17.9%N/A2.5 $2.30 2/28/2023119,500 shares $423,902.35 -42.5%N/A2.3 $3.55 2/15/2023207,900 shares $685,924.47 -32.3%N/A3.7 $3.30 1/31/2023307,200 shares $915,456.00 -17.6%N/A4.8 $2.98 1/15/2023372,900 shares $976,998.00 +0.7%N/A4.1 $2.62 12/30/2022370,400 shares $692,648.00 -8.6%N/A3.8 $1.87 12/15/2022405,300 shares $656,586.00 -7.8%N/A4.1 $1.62 11/30/2022439,700 shares $892,591.00 +6.1%N/A4 $2.03 11/15/2022414,300 shares $592,449.00 -39.7%N/A3.6 $1.43 10/31/2022687,300 shares $1.34 million -3.0%N/A6 $1.95 10/15/2022708,800 shares $886,567.04 +5.6%N/A6.6 $1.25 9/30/2022671,500 shares $859,520.00 -19.7%N/A7.7 $1.28This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 9/15/2022836,600 shares $1.24 million -8.8%N/A7.1 $1.48 8/31/2022917,200 shares $1.91 million +4.2%N/A8.4 $2.08 8/15/2022880,400 shares $2.25 million +6.3%N/A7.9 $2.55 7/31/2022828,000 shares $2.05 million +8.7%N/A7 $2.48 7/15/2022761,800 shares $2.02 million 0.0%N/A6.7 $2.65 6/30/2022762,100 shares $1.87 million -1.3%N/A6.7 $2.45 6/15/2022771,900 shares $3.32 million +9.2%N/A7.5 $4.30 5/31/2022706,800 shares $2.78 million -12.9%N/A6.3 $3.94 5/15/2022811,200 shares $3.59 million +9.7%N/A7.1 $4.43 4/30/2022739,600 shares $3.75 million +1.4%N/A6.6 $5.07 4/15/2022729,200 shares $4.26 million +8.5%N/A6.1 $5.84 3/31/2022671,900 shares $4.65 million No ChangeN/A5.4 $6.92 3/15/2022671,900 shares $4.25 million +15.8%N/A5.5 $6.33 2/28/2022580,300 shares $5.38 million +1.2%N/A4.6 $9.27 2/15/2022573,200 shares $6.28 million +0.3%N/A4.8 $10.95 1/31/2022571,600 shares $7.23 million -14.5%N/A4.8 $12.65 1/15/2022668,800 shares $10.29 million +26.0%N/A6 $15.38 12/31/2021530,800 shares $8.44 million +5.2%N/A5.1 $15.90 12/15/2021504,400 shares $7.55 million -0.1%N/A5.1 $14.96 11/30/2021505,100 shares $9.34 million -0.8%N/A5.1 $18.50 11/15/2021509,300 shares $11.17 million -0.9%N/A5.4 $21.94 10/29/2021513,700 shares $12.78 million +15.5%N/A5.1 $24.87 10/15/2021444,700 shares $10.97 million -9.6%N/A4.4 $24.66 9/30/2021491,900 shares $9.86 million +45.3%N/A5.1 $20.05 9/15/2021338,500 shares $6.06 million +20.7%N/A3.4 $17.91 8/31/2021280,500 shares $7.83 million -27.5%N/A3.1 $27.92 8/13/2021387,100 shares $10.78 million -18.1%N/A4.4 $27.84 7/30/2021472,600 shares $14.20 million +0.3%N/A6 $30.05 7/15/2021471,000 shares $12.54 million +7.5%N/A5.5 $26.62 6/30/2021438,300 shares $13.53 million -11.3%N/A4.3 $30.86 6/15/2021494,100 shares $16.31 million -1.5%N/A4.8 $33.00 5/28/2021501,500 shares $16.53 million +2.6%N/A4.5 $32.96 5/14/2021488,700 shares $14.03 million +11.1%N/A3.6 $28.70 4/30/2021439,700 shares $13.09 million +11.7%N/A3.3 $29.78 4/15/2021393,600 shares $10.24 million +11.8%N/A2.7 $26.02 3/31/2021352,100 shares $8.98 million +14.1%N/A2.6 $25.50 3/15/2021308,600 shares $9.57 million +243.7%N/A2.3 $31.01 2/26/202189,800 shares $2.09 million -70.5%N/A0.8 $23.30 2/12/2021304,100 shares $7.92 million +225.9%N/A3 $26.03 1/29/202193,300 shares $2.36 million -69.4%N/A1 $25.33 1/15/2021305,200 shares $6.81 million No ChangeN/A3.7 $22.32 RNLX Short Interest - Frequently Asked Questions What is Renalytix's current short interest? Short interest is the volume of Renalytix shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 446,600 shares of RNLX short. Learn More on Renalytix's current short interest. What is a good short interest ratio for Renalytix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNLX shares currently have a short interest ratio of 1.0. Learn More on Renalytix's short interest ratio. Is Renalytix's short interest increasing or decreasing? Renalytix saw a decline in short interest in May. As of May 15th, there was short interest totaling 446,600 shares, a decline of 28.8% from the previous total of 627,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Renalytix's short interest compare to its competitors? Here is how the short interest of companies compare to Renalytix: MariaDB plc (0.41%), MultiSensor AI Holdings, Inc. (0.69%), Exagen Inc. (0.34%), RF Industries, Ltd. (0.09%), Franklin Wireless Corp. (0.12%), Pixie Dust Technologies, Inc. (0.04%), TransAct Technologies Incorporated (0.49%), Nortech Systems Incorporated (0.41%), Interlink Electronics, Inc. (0.60%), The9 Limited (0.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Renalytix stock? Short selling RNLX is an investing strategy that aims to generate trading profit from Renalytix as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Renalytix? A short squeeze for Renalytix occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNLX, which in turn drives the price of the stock up even further. How often is Renalytix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNLX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MariaDB Short Squeeze MultiSensor AI Short Squeeze Exagen Short Squeeze RF Industries Short Squeeze Franklin Wireless Short Squeeze Pixie Dust Technologies Short Squeeze TransAct Technologies Short Squeeze Nortech Systems Short Squeeze Interlink Electronics Short Squeeze The9 Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNLX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renalytix Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.